{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:10:31Z","timestamp":1791216631510,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.chom.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T14:30:22Z","timestamp":1363185022000},"page":"250-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development"],"prefix":"10.1016","volume":"13","author":[{"given":"Jacqueline\u00a0M.","family":"Achkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2013.02.009_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2009.03967.x","article-title":"The protective role of antibody responses during Mycobacterium tuberculosis infection","volume":"157","author":"Abebe","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl 4","key":"10.1016\/j.chom.2013.02.009_bib2","doi-asserted-by":"crossref","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","article-title":"Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response","volume":"204","author":"Achkar","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/CVI.00503-09","article-title":"Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status","volume":"17","author":"Achkar","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1479-0556-9-5","article-title":"B cells can modulate the CD8 memory T\u00a0cell after DNA vaccination against experimental tuberculosis","volume":"9","author":"Almeida","year":"2011","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.chom.2013.02.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.chom.2013.02.009_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib7","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0962-8479(05)80013-9","article-title":"Humoral immune response in infants after BCG vaccination","volume":"76","author":"Beyazova","year":"1995","journal-title":"Tuber. Lung Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib9","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/jcm.34.7.1854-1855.1996","article-title":"Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study","volume":"34","author":"Boggian","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib10","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.164.12.6417","article-title":"Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology","volume":"164","author":"Bosio","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1086\/368096","article-title":"Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Gu\u00e9rin vaccination","volume":"187","author":"Brown","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/eji.200636764","article-title":"IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB\/c mice","volume":"37","author":"Buccheri","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2008.09.001","article-title":"Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy","volume":"89","author":"Buccheri","year":"2009","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.chom.2013.02.009_bib14","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.molimm.2009.07.015","article-title":"Multiple routes of complement activation by Mycobacterium bovis BCG","volume":"46","author":"Carroll","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib15","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/iai.63.11.4211-4218.1995","article-title":"Antibody immunity and invasive fungal infections","volume":"63","author":"Casadevall","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib16","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/IAI.71.8.4225-4228.2003","article-title":"Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle","volume":"71","author":"Casadevall","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.04.027","article-title":"The methodology for determining the efficacy of antibody-mediated immunity","volume":"291","author":"Casadevall","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.chom.2013.02.009_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro732","article-title":"The damage-response framework of microbial pathogenesis","volume":"1","author":"Casadevall","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","article-title":"Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases","volume":"11","author":"Casadevall","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2013.02.009_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.2184","article-title":"A new synthesis for antibody-mediated immunity","volume":"13","author":"Casadevall","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2012.04.004","article-title":"Recent progress in vaccines against fungal diseases","volume":"15","author":"Cassone","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib22","unstructured":"CDC (2012). Vaccines and immunizations: rubella. http:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/rubella.html#."},{"key":"10.1016\/j.chom.2013.02.009_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsim.2004.01.004","article-title":"Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge","volume":"41","author":"Chambers","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.2007.0648","article-title":"Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis","volume":"27","author":"Chang-hong","year":"2008","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.chom.2013.02.009_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2011.06.003","article-title":"Tuberculosis vaccines: progress and challenges","volume":"32","author":"Checkley","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chom.2013.02.009_bib26","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/eji.200425045","article-title":"Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM","volume":"34","author":"Ciurana","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.chom.2013.02.009_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/br.38.4.371-402.1974","article-title":"Vaccines and cell-mediated immunity","volume":"38","author":"Collins","year":"1974","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.chom.2013.02.009_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/517815","article-title":"Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies","volume":"177","author":"Conti","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0035-9203(92)90192-F","article-title":"Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?","volume":"86","author":"Costello","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.chom.2013.02.009_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prrv.2007.04.008","article-title":"Clinical manifestations of tuberculosis in children","volume":"8","author":"Cruz","year":"2007","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.chom.2013.02.009_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","article-title":"The role of the granuloma in expansion and dissemination of early tuberculous infection","volume":"136","author":"Davis","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.chom.2013.02.009_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12098-008-0222-3","article-title":"Serological diagnosis of tuberculosis","volume":"75","author":"Dayal","year":"2008","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.chom.2013.02.009_bib34","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1128\/IAI.73.10.6711-6720.2005","article-title":"Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies","volume":"73","author":"de Valli\u00e8re","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0962-8479(96)90008-8","article-title":"Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients","volume":"77","author":"Di Perri","year":"1996","journal-title":"Tuber. Lung Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.chom.2013.02.009_bib37","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/S0140-6736(10)60580-6","article-title":"Age and the epidemiology and pathogenesis of tuberculosis","volume":"375","author":"Donald","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2013.02.009_bib38","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.4049\/jimmunol.163.8.4087","article-title":"Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection","volume":"163","author":"Edelson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.molimm.2009.11.005","article-title":"Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis","volume":"47","author":"Encinales","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1574-695X.2006.00087.x","article-title":"Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration","volume":"47","author":"Giri","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tube.2006.01.008","article-title":"The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy","volume":"86","author":"Glatman-Freedman","year":"2006","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.chom.2013.02.009_bib42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CMR.11.3.514","article-title":"Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis","volume":"11","author":"Glatman-Freedman","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chom.2013.02.009_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/IAI.68.1.335-341.2000","article-title":"Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M","volume":"68","author":"Glatman-Freedman","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib44","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/JCM.42.7.3225-3231.2004","article-title":"Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan","volume":"42","author":"Glatman-Freedman","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib45","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.micinf.2006.04.025","article-title":"A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens","volume":"8","author":"Grover","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.chom.2013.02.009_bib46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.micinf.2005.12.004","article-title":"Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice","volume":"8","author":"Guirado","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.chom.2013.02.009_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0962-8479(97)90012-5","article-title":"Serological diagnosis of childhood tuberculosis by estimation of mycobacterial antigen 60-specific immunoglobulins in the serum","volume":"78","author":"Gupta","year":"1997","journal-title":"Tuber. Lung Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib48","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/CDLI.5.2.211-218.1998","article-title":"Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis","volume":"5","author":"Hetland","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2013.02.009_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.chom.2013.02.009_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1473-3099(11)70146-3","article-title":"Fact and fiction in tuberculosis vaccine research: 10 years later","volume":"11","author":"Kaufmann","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib54","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1016\/j.vaccine.2011.10.019","article-title":"BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity","volume":"29","author":"Keyser","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.vaccine.2007.12.005","article-title":"Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) in infected mice","volume":"26","author":"Kohama","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CMR.00014-11","article-title":"Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery","volume":"24","author":"Kunnath-Velayudhan","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chom.2013.02.009_bib57","doi-asserted-by":"crossref","first-page":"14703","DOI":"10.1073\/pnas.1009080107","article-title":"Dynamic antibody responses to the Mycobacterium tuberculosis proteome","volume":"107","author":"Kunnath-Velayudhan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2013.02.009_bib58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/jis421","article-title":"Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients","volume":"206","author":"Kunnath-Velayudhan","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib59","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijmm.2008.10.007","article-title":"Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection","volume":"299","author":"L\u00f3pez","year":"2009","journal-title":"Int. J. Med. Microbiol."},{"issue":"Suppl\u00a01","key":"10.1016\/j.chom.2013.02.009_bib61","doi-asserted-by":"crossref","first-page":"i92","DOI":"10.1136\/ard.2009.117101","article-title":"The pro and\u00a0anti-inflammatory activities of immunoglobulin G","volume":"69","author":"Lux","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib62","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/IAI.66.8.3936-3940.1998","article-title":"Heterogeneous antibody responses in tuberculosis","volume":"66","author":"Lyashchenko","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vetmic.2008.05.029","article-title":"Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife","volume":"132","author":"Lyashchenko","year":"2008","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.chom.2013.02.009_bib64","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/eji.200839148","article-title":"How B cells shape the immune response against Mycobacterium tuberculosis","volume":"39","author":"Maglione","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib65","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib66","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.4049\/jimmunol.180.5.3329","article-title":"Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection","volume":"180","author":"Maglione","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.191.2.287","article-title":"Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages","volume":"191","author":"Malik","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.chom.2013.02.009_bib68","first-page":"542","article-title":"Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages","volume":"50","author":"Manivannan","year":"2012","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.chom.2013.02.009_bib69","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1172\/JCI38322","article-title":"Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism","volume":"120","author":"McClelland","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chom.2013.02.009_bib70","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1128\/IAI.01457-08","article-title":"CD23 mediates antimycobacterial activity of human macrophages","volume":"77","author":"Mossalayi","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib71","first-page":"88","article-title":"Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan","volume":"10","author":"Navoa","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib72","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib73","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chom.2013.02.009_bib74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tube.2006.01.006","article-title":"The effect of the administration of human gamma globulins in a model of BCG infection in mice","volume":"86","author":"Olivares","year":"2006","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.chom.2013.02.009_bib75","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.vaccine.2008.05.050","article-title":"The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response","volume":"26","author":"Palma","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.02.009_bib77","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib78","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.vaccine.2004.11.032","article-title":"Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG","volume":"23","author":"Rodr\u00edguez","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.02.009_bib79","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1128\/IAI.73.9.6101-6109.2005","article-title":"Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice","volume":"73","author":"Roy","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib80","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMcibr0902539","article-title":"The granuloma in tuberculosis\u2014friend or foe?","volume":"360","author":"Rubin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2013.02.009_bib81","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.imbio.2010.01.003","article-title":"B-1 cell protective role in murine primary Mycobacterium bovis bacillus Calmette-Guerin infection","volume":"215","author":"Russo","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.chom.2013.02.009_bib82","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/infdis\/162.4.928","article-title":"An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis","volume":"162","author":"Sada","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chom.2013.02.009_bib83","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1440-1711.2000.00933.x","article-title":"Restraining mycobacteria: role of granulomas in mycobacterial infections","volume":"78","author":"Saunders","year":"2000","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.chom.2013.02.009_bib84","series-title":"Sue Golding Graduate Division of Medical Sciences","article-title":"The carbohydrate surface of M. tuberculosis: antigenicity and antibody immunity","author":"Schwebach","year":"2002"},{"key":"10.1016\/j.chom.2013.02.009_bib85","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/CVI.00355-08","article-title":"Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis","volume":"16","author":"Steingart","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib86","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1440-1843.1996.tb00021.x","article-title":"Effect of antibacterial antibody on bactericidal activities of superoxide and lysosomal enzyme from alveolar macrophages in rabbits","volume":"1","author":"Suga","year":"1996","journal-title":"Respirology"},{"key":"10.1016\/j.chom.2013.02.009_bib87","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2013.02.009_bib88","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CVI.00151-06","article-title":"DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB\/c mice","volume":"13","author":"Teixeira","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib89","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/dxl017","article-title":"Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice","volume":"18","author":"Tj\u00e4rnlund","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib90","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2249.1996.d01-845.x","article-title":"Increase of tuberculous infection in the organs of B cell-deficient mice","volume":"106","author":"Vordermeier","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib91","doi-asserted-by":"crossref","first-page":"e18289","DOI":"10.1371\/journal.pone.0018289","article-title":"IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway","volume":"6","author":"Vouldoukis","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.chom.2013.02.009_bib92","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.chom.2013.02.009_bib93","unstructured":"World Health Organization (2012). Global tuberculosis report 2012. Geneva, Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/."},{"key":"10.1016\/j.chom.2013.02.009_bib94","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/IAI.72.11.6324-6329.2004","article-title":"RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection","volume":"72","author":"Xue","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.02.009_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00176-11","article-title":"Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing","volume":"2","author":"Yano","year":"2011","journal-title":"mBio."},{"key":"10.1016\/j.chom.2013.02.009_bib96","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/CVI.05550-11","article-title":"Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status","volume":"19","author":"Yu","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.chom.2013.02.009_bib97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellimm.2012.01.007","article-title":"CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses","volume":"274","author":"Zhang","year":"2012","journal-title":"Cell. Immunol."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312813000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312813000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:13:32Z","timestamp":1761826412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312813000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1931312813000759"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2013.02.009","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-Mediated Immunity against Tuberculosis: Implications for Vaccine Development","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}